CIK 0001177648
- Non-accelerated filer
- Smaller reporting company
ENANTA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ENTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Entity type
- Operating
- EIN
- 043205099
- Phone
- +1 617-607-0800
- Business address
- 4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-01 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −7,495 | $85.02 | $637K | 27,044 |
| 2021-11-01 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −100 | $86.21 | $9K | 26,944 |
| 2021-11-01 | Adda Nathalie Sr. VP & Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −9,547 | 13,953 | ||
| 2021-10-11 | Adda Nathalie Sr. VP & Chief Medical Officer | Option exercise | +4,047 | $43.46 | $176K | 30,991 |
| 2021-10-11 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −4,047 | $70.34 | $285K | 26,944 |
| 2021-10-11 | Adda Nathalie Sr. VP & Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −4,047 | 54,770 | ||
| 2021-10-08 | Adda Nathalie Sr. VP & Chief Medical Officer | Option exercise | +13,453 | $43.46 | $585K | 40,397 |
| 2021-10-08 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −13,453 | $70.09 | $943K | 26,944 |
| 2021-10-08 | Adda Nathalie Sr. VP & Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −13,453 | 58,817 | ||
| 2021-09-15 | Luly Jay R. President and CEO | Sale | −4,516 | $59.06 | $267K | 676,972 |
| 2021-08-19 | Hata Yujiro S Director | Grant or award · Stock Option (right to buy) | +13,144 | 13,144 | ||
| 2021-03-02 | Vance Terry Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2021-03-02 | Russell Lesley Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2021-03-02 | Peterson Kristine Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2021-03-02 | FOLETTA MARK G Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2021-03-02 | CARTER BRUCE L A Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2021-01-26 | Or Yat Sun Sr. VP & CSO | Option exercise | +5,149 | $14.18 | $73K | 322,374 |
| 2021-01-26 | Or Yat Sun Sr. VP & CSO | Option exercise | +3,672 | $11.77 | $43K | 326,046 |
| 2021-01-26 | Or Yat Sun Sr. VP & CSO | Option exercise | +4,872 | $11.77 | $57K | 330,918 |
| 2021-01-26 | Or Yat Sun Sr. VP & CSO | Option exercise · Stock Option (Right to Buy) | −5,149 | 0 |
Page 17 of 19 · 377 trades